The mining
industry has rarely been seen at the forefront of environmental
protection. Nearly by definition mining
requires disruption of the earth to tease out coveted metals and minerals and
then mold and manipulate them into everything from tools to temples for the satisfaction
of humans. It has been like that since
our ancestors crafted the first spears from iron and later from a clever mix of
copper and tin. In the 1990s scientists
discovered that copper contamination is present in 7,000-year old layers of ice
in the Greenland glacial caps. At its
greatest strength Rome produced nearly 17,000 tons of copper annually. Copper smelting ate up vast forests for fuel and
produced ultra-fine particle dust that was carried far and wide by thermal
plumes from smelter fires. The smelting
process for bronze made with arsenic produced fumes no less poisonous then than
it is now.
Unlike the good
old days of the Roman emperors, we have learned a thing or two about mitigating
pollution. It is not necessary to put up
with arsenic poisoning for the sake of convenience of copper water pipes. One particularly interesting avenue for
environmentally friendly mining is ‘biohydrometallury.’ This is now a special branch of biotechnology
that deploys bacteria for industrial uses such as microbial mining, oil
recovery, bioleaching and microbial water treatment.
BHP Billiton Plc. (BHP:
NYSE) has been at the forefront of biohydrometallurgy and has patented a several bio-solutions the company is using in its
mining operations. The BHP BioCOP
process can be used to treat concentrates not suitable for commercial smelting
because of the presence of arsenic or other environmentally unfriendly
elements. BioCOP relies on thermophilic
microorganisms to leach copper sulphide mineral concentrates. Then the copper is recovered by conventional
solvent extraction. BHP’s BioNIC and
BioZINC processes are used for leaching of nickel and zinc sulfides,
respectively. These microorganisms
catalyze the oxidation of sulfide materials.
This is different than conventional acid leaching of only oxidized
minerals.
BHP spoke out a
great deal more on its biomining efforts in years past. However, fortunes appeared to be against
them. A joint venture with Codeco in
Chile was abandoned in 2006. More
recently BHP’s microbes have taken a back seat to more pressing issues. The fiscal year ending June 2016, was
challenging. The company reported $30.1
billion in total sales in the year, 31% lower than the previous fiscal year on
weak commodity prices and lower demand.
The year ended in a $6.4 billion loss after BHP was forced to write down
oil and gas assets. Additionally, a dam
failure at an iron ore mine in Brazil jointly owned by BHP and Vale resulted in
numerous deaths and the joint venture is being sued by the Brazilian government
for environmental damages.
Fortunately for friends
of the environment, BHP Billiton is not the only player in the
biohydrometallurgy game. BacTech
Environmental (BAC: CSE or BCCEF: OTC/QB) has developed a
proprietary technology to remediate mine tailings and prevent contamination of
waterways by acid drainage. Tailings
might still contain useful minerals or metals, but can also hold highly toxic
substances such as arsenic and mercury.
Acid drainage from thousands of mine sites around the world is a major
source of water and soil contamination.
BacTech uses
bacteria to oxidize sulphide in the leftover mining materials. The process stabilizes the toxic substances
and captures both precious and base metals for commercial sale. The process replaces the usual practice of
treating water discharge from mine tailings, which typically is required for
decades. With the chance of recovering
commercially viable metals from the tailings, BacTech has a strong value
proposition against the conventional water treatment system.
In association
with the Bolivian government mining agency, COMIBOL, the company has
established a silver and copper tailings project in that country called
Telamayu. Early assay work suggests
there are significant silver, copper, tin, indium and germanium in the
tailings. BacTech is also in discussions
with a private company to treat ores at sites in Peru and Ecuador for recovery
of gold and arsenic. The company already
has constructed and commission three gold/arsenic plants in Tasmania, China and
Australia.
Unfortunately,
none of those achievements have generated revenue. The company appears to be adhering to a
frugal operating budget with cash usage by operations limited to CAD$99,114 in
the first half of 2016. Nonetheless,
BacTech is not well capitalized. Cash resources at the end of June 2016,
totaled a very modest CAD$6,475 and current liabilities totaled CAD$1.9
million.
The company
recently raised CAD$500,000 in new capital to pay off a $150,000 loan and to
undertake additional metallurgical studies for its Telamayu project. The added work will be in support of
conventional gravity and flotation processes and not for an expansion of the
bioleach operation there. Production
from this site is expected in 2017.
The company is
likely to need additional capital.
Equipment for a flotation system capable of processing 250 tons per day
bears a price tag near US$ million. Even
a small-scale bioleach circuit capable of processing 40 tons per day requires
an outlay near US$8 million.
BacTech shares
can only be described as speculative.
While the technological capabilities of microbes in mining appear to be
well established by several developers, BacTech still has much to prove in its
business model. The company has yet to
deliver a steady stream of revenue and earnings and still has only a few
commercial relationships. Nonetheless,
for it is an interesting target for risk tolerant environmentalists.
Neither the author of the Small Cap Strategist web
log, Crystal Equity Research nor its affiliates have a beneficial interest in
the companies mentioned herein.
No comments:
Post a Comment